NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Alt Biotech

Alt Biotech

Private
FranceHealthcare & Life Scienceshttps://www.alt-biotech.com/

Last Round

Grant

Sep 18, 2024

Total Funding Raised

$661,000

Company Overview

Alt Biotech is a biotechnology company that develops an innovative bioproduction method to generate affordable, high-quality growth factors, cytokines, and hormones for cell culture.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

animal-free growth factorsrecombinant proteinscellular agriculturelab-grown meatbioproductioncell culture mediacytokinescell therapycultivated meatmicrobial engineeringregenerative medicinebiotech reagentsfetal bovine serum replacementFBS alternativeorganoid development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Alt Biotech Comps

Public and private peers based on sector, stage, and business model.

Alt Biotech comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Alt Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 18, 2024
AcceleratorJan 25, 2024
DebtNov 2, 2023
AcceleratorMay 23, 2023

Alt Biotech Investors

Notable investors and investment history

Alt Biotech investors
InvestorRounds
Biotope by VIBAccelerator
Ministry of Higher Education and ResearchGrant
GenopoleDebt
BpifranceGrant
CDG InvestAccelerator
212 FoundersAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 18, 2024

    $640K grant received from Bpifrance and Ministry of Higher Education and Research.

Alt Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Alt Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Alt Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersFrance
Year Founded2023
Last FundingSep 18, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.